Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
BNN20200115BUndetermined Publication Date: 2022-08-03AMGEN INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- BNN20200115
- Authority / Receiving Office
- BN · BN
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-11-10
- Filing Date
- 2020-12-23
- Publication Date
- 2022-08-03
- Estimated Expiration
- 2040-12-23
Abstract
Methods of treating metabolic diseases and disorders using an antigen binding protein specific for the GIPR polypeptide are provided. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy. In certain embodiments the antigen binding protein is administered in combination with a GLP-1 receptor agonist.
Need to check novelty before this filing date? Find Prior Art